On the financial front, Biocon recently raised ₹4,500 crore through a qualified institutional placement (QIP), its first capital raise since its initial public offering (IPO) over 20 years ago…
Biocon Biologics eyes global expansion with focus on insulin and GLP-1 therapies



GIPHY App Key not set. Please check settings